Maxivax SA
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCC (NCT02999646) | Maxivax SA | 2018-07-25 |
Track Maxivax SA automatically
Every clearance here is in the API, with alerts when new ones post.